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ABSTRACT 
Food-drug interactions occur as a result of pharmacokinetic or pharmacodynamics mechanisms. Pharmacokinetic mechanisms include what the 
body does to a drug while Pharmacodynamics mechanisms involve what drugs do to the body. Many types of food have been shown to influence 
metabolism and the absorption of drugs. Large numbers of drugs are produced and introduced yearly. The interaction between Food and drug may 
cause negative effects in the nutritional status of the patient as well as safety and efficacy of drug therapy. Due to the possibility of unexpected or 
poor outcomes, generally, food-drug interactions, in this case, should be avoided. As the good clinical practice, drugs taken by mouth must be 
absorbed either through the lining of the stomach or the small intestine. Reduction in the absorbance of a drug might be influenced by the presence 
of food in the digestive tract. The avoidance of such interactions could be possible if the drug is taken 1 hour before or 2 h after eating the food. The 
effects of several types of food such as milk or milk products, grapefruit and grapefruit juice, bananas, oranges, legumes, fermented meats and 
pickled fish and some nutrient elements such as calcium, potassium, magnesium, iron, zinc, and vitamin K are highlighted in this paper including 
their clinical implications. 
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Many types of medicines can be useful because of their positive 
effects in treating and curing many health problems. To ensure that 
these medicines are safe and effective they must be taken properly. 
So, medications should have the same predictable effect for all 
patients, extremely specific in their effects, exhibit linear potency, 
never be affected by concomitant food or other medications, be 
totally non-toxic in any dosage and require only a single dose to 
affect a permanent cure [1]. Some types of food can sometimes have 
a significant impact on some drugs. Ayo et al. [2], revealed that a 
drug interaction is a situation in which a substance affects the 
activity of a drug, i.e. they produce a new effect that neither 
produces on its own or the effects are increased or decreased. Like 
drug-drug interaction (3), the interactions may also exist between 
foods and drugs (food-drug interactions) and could be possible 
between drugs and herbs (drug-herb interactions). The interactions 
between food and drugs may inadvertently reduce the absorbance of 
drug and also may increase the negative effect of the drug. However, 
due to the physiological response to food intake, particularly the 
gastric acid secretion, may increase or reduce the bioavailability of 
certain drugs [4]. Earlier (Schmidt and Dalhoff [5], reported that 
these may occur due to the lack of knowledge about the active 
ingredients that involved in the relevant substances. Several types of 
research have been dedicated with the objectives of investigating the 
effects of certain food-drug interaction systems [6-17]. The aim of 
the present was to investigate and highlight the effect of food-drug 
systems and their various clinical implications. 
General food/some food components-drug interaction 
Some specific types of foods can have unique influences on drug 
interaction and disposition. Within the gastrointestinal tract, an oral 
administration of a drug concurrent with meal alters may influence 
the rate or extent of drug absorption as well as the physicochemical 
conditions of the drug. Davit and Conner [18], claimed that a change 
in the rate of drug absorption is less clinically significant than a 
change in the extent of the drug absorption because due to the 
influences in bioavailability of both drug and meal. According to FDA 
[19], tested a meal contains about 800 to 1,000 kcal, with about 50% 
of calories as fat (eg, two strips of bacon, two eggs fried in butter, 
two slices of buttered toast, whole milk and brown potatoes and 
concluded that that such a meal will create the greatest perturbation 
on gastrointestinal physiology and be reflected in a meal’s influence 
on drug bioavailability. Therefore, it is very important to test meal 
conditions used in any conducted study before making a clinical 
recommendation. Using data generated invitro studies can clearly 
predict food effects and drug disposition using the Biopharmaceutics 
Classification System [19-23]. Boullata et al. [9], suggested that 
based on drug solubility and intestinal permeability some drugs 
have low solubility but high permeability and are expected to have 
an enhanced extent of absorption when administered with food. On 
the other hand, some other specific foods have impaired the 
absorption of drugs with poor permeability when examined in 
several clinical studies. 
Interaction of some vegetables with drugs 
Some vegetables (broccoli, Brussels sprouts, kale, parsley, spinach, 
and others) had a high content of vitamin K. Earlier, Holt [24] was 
reported that making sudden changes in the amounts eaten or eating 
large quantities of these vegetables interferes with the safety and 
effectiveness of warfarin therapy. Great decrease in warfarin activity 
might be resulted from eating charbroiled food. However, Zikria 
[25], revealed that eating cooked onions may increase warfarin 
activity. On the other hand, it was reported that soy foods had both 
an increase and decrease effect on warfarin activity [25], but the 
author found that the combination of cranberry juice and warfarin 
administration appeared to be associated with an elevated 
international normalized ratio without bleeding in an elderly 
patient. 
Fruit juice-drug interaction 
Several juices were found to have an interaction with medication by 
metabolizing and altering transporters enzymes to a wider degree 
than initially described [26, 27]. Naringin, an ingredient in most 
citrus fruits has been shown to reduce aliskiren uptake [28]. 
Grapefruit juice was the first identified, but based on flavonoid and 
furanocoumarin content other juices have also been shown to 
interact with medication [29, 30]. It was found that furanocoumarins 
had significant inhibition on intestinal isoenzymes and can also 
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interfere with transporters, thereby increasing oral drug 
bioavailability. Grapefruit juice was found to have a significant effect 
on Aliskiren which is recognized as a direct renin inhibitor indicated 
for the treatment of hypertension. A clinical study conducted on 11 
healthy volunteers administered using 200 ml single-strength of 
grapefruit juice (three times daily for five days) and 150 mg of 
aliskiren on day 3 showed that relative to water, grapefruit juice 
significantly reduced mean aliskiren by 61% [31]. A study with 28 
healthy volunteers receiving 300 mg aliskiren and either water or 
grapefruit juice (300 ml) revealed a decrease of 38% by of the drug 
in the presence of grapefruit juice [28]. This decrease in the 
absorption of the drug was in a good agreement with the previous 
studies by several authors [30, 33-36]. However, some clinical 
studies with certain β-blockers, fexofenadine, and fluoroquinolones 
have demonstrated that orange juice can reduce systemic exposure 
by up to 83% [39-42]. Tapaninen et al. [31] investigated the effect of 
orange juice on aliskiren. In a randomized study, 12 healthy 
volunteers ingested 200 ml of orange juice, water or apple juice for a 
frequency of three times daily for a period of five days. On day 3, the 
volunteers ingested a single dose of 150 of aliskiren. The result 
showed that orange juice reduced aliskiren geometric mean by 62% 
relative to water while having no effect on elimination half-life. 
Apple juice was also investigated on drug metabolism in vitro and in 
human volunteers [26]. The evidence exists that apple juice inhibits 
organic anion transporting polypeptides activity which recognized 
as proteins that facilitate uptake of a number of endogenous 
compounds such as hormones and bile acids [41]. Apple juice intake 
on fexofenadine was evaluated in a randomized crossover study of 
14 healthy volunteers [42]. Midazolam (5 mg) and fexofenadine (60 
mg) with 300 ml of either normal-strength apple juice or water were 
orally taken. It was found that apple juice decreased fexofenadine 
mean 79% compared to water but it did not show significant effects 
on midazolam, indicating that apple juice had minimal effect on 
midazolam activity. Some other dedicated studies have shown the 
same effect of apple juice on fexofenadine [43-47].  
Green tea-drug interaction 
Green tea (GT) is well known among the most worldwide consumed 
beverages. It is obtained from the non-fermented leaves of the Camellia 
sinensis plant. It has promising health beneficial effects and it is 
considered as one of the most important nutraceuticals that used as new 
treatment approaches for oral cancer [48]. The polyphenols of GT (GTP), 
particularly catechin ( −) epigallocatechin-3-gallate (EGCG), which has 
about 50–80% of the total catechins in GT, is reported to have an 
antioxidant effect [49]. It was investigated and reported that the anti-
carcinogenic effect of tea catechins with EGCG being the most active. 
  
Table 1: Selected food-drug interaction and their clinical implication
Food  
* 
Medicine  Type of effect Clinical implications 
Milk or milk products Ciprofloxacin(Cipro) Levofloxacin 
(Levaquin) 
 
Calcium in milk bind with these drugs 
inhibiting absorption of the drugs as 
well as calcium 
Administer 2 h before or 2 h after 




Beta-adrenergic antagonists  
Labetalol Metoproplol 
Propranolol (Inderal) 
Increased absorption by decreased 
first-pass metabolism; can slow heart 
rate and lower blood pressure 
Avoid grapefruit or grapefruit 
juice 2 h before or 1 hour 
after administration of the drug 
Bananas, oranges, 





Prevents kidneys from excreting 
potassium causing toxicity, slow heart 
rate, palpitations, and possibly cardiac 
arrest 
Limit potassium-rich foods, such as 
bananas, oranges, and green leafy 
vegetables, and salt substitutes that 
contain potassium. 
Foods that raise blood 
sugar, such as sweets 
and refined flour 
Antidiabetic drugs, Sulfonylureas 
Chlorpropamide  
Glipizide (Glucotrol) 
Reduces control of blood sugar Vitamin 
B12 deficiency and irreversible nerve 
damage 
Avoid foods containing simple sugars 
and refined flour 
Aged cheeses, fava 
beans, yeast extracts, 
Monomine oxidase; inhibitors; 
Isocarboxazid Phenelzine (Nardil), 
Tranylcypromine 
 
Potentially fatal spike in blood 
pressure 
Avoid foods and beverages containing 
tyramine or tryptophan while taking 
medications and for 2 w after 
stopping this drug. 
High-fiber products, 
such as bran, pectin, 
bulk laxatives 
Cardiac glycosides Decreases absorption of the drug Administer before 1 hour or 4 h after 
ingestion of high fiber food products 
Regular meal or snack Anti-tuberculosis; Rifampin 
(Rifadin, Rimactance). 
Delays or decreases absorption of the 
drug 
Administer 1 hour before or 2 h after 
meal or snack 
Dietary fiber and Fatty 
foods 
Simvastatin (Zocor) Lovastatin 
(Mevacor) Lovastatin (Mevacor) 
Atorvastatin (Lipitor) 
Decrease absorption of the drugs; 
cause headage and stomachage and 
muscle breakdown 
Give with low-fiber foods or 1 hour 
after administration of drugs 
Grapefruit juice Drugs that prolong repolarization 
Amiodarone (Cordarone, Pacerone 
Significantly enhanced toxicity Give on an empty stomach, 1 hour 
before or 2 h after meal or snack 
Fermented meats, 
pickled fish 
Inhibitors; monomine oxidase Potentially affect fatal spike in blood 
pressure 
Avoid these foods after taking drugs 
for 2 w. 
Soybean formulas Thyroid supplements Decreases absorption; increases fecal 
elimination 
Avoid soybean formulas and Limit 
foods high in iodine, such as rutabaga, 
soybeans, or turnips. 
High-carbohydrate 
meals 
Respiratory medications May cause nausea, vomiting, headache, 
irritability 
Avoid high-carbohydrate meals or 
supplements and when necessary 2 h 
after dose 
High-fat meals Bronchodilators 
theophylline 
Decreases absorption of the drug; May 
cause nausea, vomiting, headache, 
irritability 
Avoid high-fat meals or supplements 
and when necessary hold enteral 
nutrition 1 hour before medication. 
 
There are numerous investigations and reports in this regards [51-53]. 
GT was found to have high concentrations of catechins, including 
epigallocatechin (EGC), epicatechin (EC) and epicatechin gallate (ECG). 
Zaveri [53] studied the activity of predominant catechin extensively 
for health benefits on OATP1A2 (organic anion transporting 
polypeptide 1A2) and OATP1A2 (organic anion transporting 
polypeptide 2A1) and OATP2B1 have in vitro. He reported that both 
EGCand ECG at 100 μM inhibited OATP2B1-mediated estrone-3-
sulfate uptake by ~70%. This finding agreed with that revealed by 
Roth et al. [54] and Fuchikami et al. [55]. However, ECG showed higher 
potency than EGCG (IC50 of 36 vs. 100 μM) [52]. Moreover, they 
reported that ECG at 100 μM also inhibited OATP1A2-mediated 
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estrone-3-sulfate uptake by ~75% but ECG again showed higher 
potency than (IC50
 
 of 10 vs. 55 μM). The consumption of a cup of GT 
(e. g., 240–300 ml) or two cups of GT will result in inhibition of OATP 
activity due to high concentrations of ECG in intestinal line. 
Table 2: Selected nutrient-drug interaction and their clinical implication
Nutrient in food  
* 
Medicine  Type of effect Clinical implications 
Calcium 
 
Ciprofloxacin (Cipro) Calcium binds with these drugs 
inhibiting absorption of the drugs 
Hold enteral feeding 1 hour before and 2 h 
after administration of the drug. 
Potassium  Diuretics, thiazide; Chlorthalidone 
(Hygroton) 
Causes loss of potassium and 
magnesium; can cause rapid heart 
rate and arrhythmias 
Administer potassium/magnesium 
supplement or foods such as apricots, 
bananas, cantaloupe, dairy foods, dried 
beans, lentils, oranges, and tomatoes. 
Magnesium Quinolones Magnesium binds with this drugs 
inhibiting absorption of the drugs 




Gastrointestinal Medications Calcium toxicity and kidney 
failure 
Avoid milk; milk products and calcium 
supplement 
Aluminum Levofloxacin (Levaquin) Aluminum binds with this drugs 
inhibiting absorption of the drugs 
Avoid meals contain aluminum and 
aluminum supplement 
Iiron  Norfloxacin (Noroxin) Iron binds with this drugs 
inhibiting absorption of the drugs 
Avoid meals contain iron and iron 
supplement 
Zinc Ofloxacin (Floxin Zinc binds with this drugs 
inhibiting absorption of the drugs 
Avoid meals contain zinc and zinc 
supplement 
Vitamin B12 Proton-pump inhibitors Vitamin B12 deficiency if used 
long term 
Avoid foods rich in Vitamin B12 
Meals that high in 
pyridoxine (B6) 
Antiparkinson drugs Decreases absorption of the drug, 
increases symptoms 
Limit foods rich in pyridoxine such as 
chicken, fish, liver, and kidney. 
Vitamin K Medications affecting the blood and 
blood-forming organs anticoagulant 
such as warfarin (Coumadin)  
increases chance of blood clots  Limit foods high in vitamin K such as 




Medications affecting the blood and 
blood-forming organs anticoagulant 
such as 
Prolongs clotting time and 
increases the risk of bleeding 
Avoid foods rich or foods, such as leafy green 
vegetables, antagonize action; soy proteins; 
high doses of vitamin E (400 IU) 
High-potassium 
supplements 
 Potassium toxicity can slow heart 
rate and possibly cause cardiac 
arrest 
Avoid excessive potassium intake including 
salt substitutes that contain potassium. 
Iodine Metformin (Glucophage) Decreases absorption; increases 
fecal elimination 
Limit foods high in iodine, such as brussels 
sprouts, cabbage, rutabaga, soy beans. 
*
 
Harrington and Gonzales, 2004) [50] 
CONCLUSION  
Food-drug interaction is considered a critical issue and most studies 
in this regard are conducted to evaluate appropriate dosing, 
formulation of new drug candidates and intake timing. Commonly 
consumed foods could have inhibition effect on drug or either 
increase/decrease the absorption of certain drugs. Foods should be 
tested comprehensively before taking certain drugs to avoid the 
possibility of interaction with the drug. Therefore patients are 
advised to tell their doctors and pharmacists about their food intake 
and dietary supplements so that serious interactions between foods 
and drugs can be avoided. Carefully following the clinical 
implications in this article is highly suggested and recommended. 
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